Literature DB >> 30870049

Staged immediate nipple reconstruction with tube flap in secondary autologous breast reconstruction.

Jiasheng Dong1, Tao Wang1, Yi Zhang1, Hua Xu1, Jinguang He1.   

Abstract

In the setting of secondary breast reconstruction by deep inferior epigastric artery perforator (DIEP) flap, the mastectomy skin is usually deepithelialized and buried under the reconstructed breast. In this study, by virtue of tube flap technique, we hypothesize that an amount of mastectomy skin could be transferred to the apex of reconstructed breast mound for nipple reconstruction. A total of 30 female postmastectomy patients were recruited between June 2012 and August 2015. A bipedicle DIEP flap was harvested and folded upward to reconstruct the breast. An inferiorly based mastectomy flap was raised and rolled into a tube. The free end of the flap was sutured to the reconstructed breast mound to allow revascularization. After serial stages, a sufficient tissue bulk from the mastectomy flap was transferred to the apex of the breast mound and remolded into a new nipple. Reconstructed breasts and nipples survived well postoperatively. The mean nipple projection was 9.2 ± 2.7 mm at the 1-year follow-up. In total 24 patients ranked the overall nipple and breast reconstruction to be very good or good. Based on DIEP flap breast reconstruction, the staged immediate nipple reconstruction with local mastectomy tube flap could maintain a long term residual projection with aesthetically acceptable outcomes.

Entities:  

Keywords:  DIEP flap; breast reconstruction; immediate; mastectomy flap; nipple reconstruction; tube flap

Mesh:

Year:  2019        PMID: 30870049     DOI: 10.1080/2000656X.2019.1582423

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  1 in total

1.  Three Cases of Bilateral Breast Absence Associated with Familial Congenital Ectodermal Defects.

Authors:  Shunqing Su; Rurong Xie; Xiumei Ding; Yuechun Lin
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.